Tolerability of azithromycin as malaria prophylaxis in adults in Northeast Papua, Indonesia

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 7, 2003, Pages 2199-2203

  Taylor, Walter R ^a,d,g   Richie, Thomas L ^a   Fryauff, David J ^a   Ohrt, Colin ^e   Picarima, Helena ^a   Tang, Douglas ^e   Murphy, Gerald S ^a   Widjaja, Hendra ^a   Braitman, David ^f   Tjitra, Emiliana ^b   Ganjar, Asep ^c   Jones, Trevor R ^a   Basri, Hasan ^a   Berman, Josh ^e  

^a US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c District Military Health Services   (Indonesia)

^d TULANE UNIVERSITY   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^f US Army Medical Materiel Development Activity   (United States)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; PLACEBO; PRIMAQUINE;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; BLOOD TOXICITY; CHEMOPROPHYLAXIS; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; HALLUCINATION; HEADACHE; HEARING LOSS; HEARTBURN; HUMAN; INDONESIA; INSOMNIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALARIA; MALE; MYALGIA; NAUSEA; NEPHROTOXICITY; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; RASH; SELF REPORT; SWEATING; TINNITUS; VISUAL IMPAIRMENT; VOMITING;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; FEMALE; HUMANS; INDONESIA; MALARIA, FALCIPARUM; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES;

EID: 0037636534     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.7.2199-2203.2003     Document Type: Article

References (25)

1. Andersen, S. L., A. J. Oloo, D. M. Gordon, O. B. Ragama, G. M. Aleman, J. D. Berman, D. B. Tang, M. W. Dunne, and G. D. Shanks. 1998. Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clin. Infect. Dis. 26:146-150.
2. Bailey, R. L., P. Arullendran, H. C. Whittle, and D. C. W. Mabey. 1993. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 342:453-456.
3. Brown, B. A., D. E. Griffith, W. Girard, J. Levin, and R. J. Wallace. 1997. Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease. Clin. Infect. Dis. 24:958-964.
4. Cascaval, R. I., and D. J. Lancaster. 2001. Hypersensitivity syndrome associated with azithromycin. Am. J. Med. 25:483-484.
5. Ederer, F., and N. Mantel. 1974. Confidence limits on the ratio of two Poisson variables. Am. J. Epidemiol. 100:165-167.
6. Farrington, C. P., and G. Manning. 1990. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat. Med. 9:1447-1454.
7. Ferwerda, A., H. A. Moll, W. C. Hop, J. M. Kouwenberg, C. V. Tjon Pian Gi, S. G. Robben, and R. de Groot 2001. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections. J. Antimicrob. Chemother. 47:441-446.
8. Glynn, R. J., and J. E. Buring. 1996. Ways of measuring rates of recurrent events. BMJ 312:364-367.
9. Griffith, D. E., B. A. Brown, W. M. Girard, D. T. Murphy, and R. J. Wallace. 1996, Azithromycin activity against Mycobacterium avium complex lung disease in patients who are not infected with human immunodeficiency virus. Clin. Infect. Dis. 23:983-989.
10. Havlir, D. V., M. P. Dube, F. R. Sattler, D. N. Forthal, C. A. Kemper, M. W. Dunne, D. M. Parenti, J. P. Lavelle, A. C. White, Jr., M. D. Witt, S. A. Bozzette, and J. A. McCutchan. 1996. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N. Engl. J. Med. 335:392-398.
11. Hopkins, S. 1996. Clinical toleration and safety of azithromycin. Am. J. Med. 91(Suppl. 3A):40S-45S.
12. Hopkins, S. J., and D. Williams. 1995. Clinical tolerability and safety of azithromycin in children. Pediatr. Infect. Dis. J. 14:S67-S71.
13. Hubner, C., A. Dietz, W. Stremmel, A. Stiëhl, and K. Andrassy. 1997. Macrolide-induced Churg-Strauss syndrome in a patient with atopy. Lancet 350:563.
14. Koopman, P. A. 1984. Confidence limits on the ratio of two proportions. Biometrics 40:513-517.
15. Longo, G., C. Valenti, G. Gandini, L. Ferrara, M. Bertesi, and G. Emilia. 1997. Azithromycin-induced intrahepatic cholestasis. Am. J. Med. 102:217-218.
16. Martin, D., T. F. Mroczkowski, Z. A. Dalu, J. McCarthy, R. B. Jones, S. J. Hopkins, and R. B. Jonson. 1992. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N. Engl. J. Med. 327:921-925.
17. Oldfield, E. C., J. Fessel, M. Dunne, G. Dickinson, M. R. Wallace, W. Byrne, R. Chung, K. F. Wagner, S. F. Paparello, D. B. Craig, G. Melcher, M. Zajdowicz, R. F. Williams, J. W. Kelly, M. Zelasky, L. B. Heifets, and J. D. Berman. 1998. Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. Clin. Infect. Dis. 26:611-619.
18. Perneger, T. V. 1998. What's wrong with Bonferroni adjustments. BMJ 316:1236-1238.
19. Rees, B. D., and E. M. Gross. 2000. Irreversible sensineural hearing loss as a result of azithromycin ototoxicity. Ann. Otol. Rhinol. Laryngol. 109:435-437.
20. Schneider, R. 1977. Doxycycline esophageal ulcers. Am. J. Dig. Dis. 22:805-807.
21. Taylor, W. R. J., T. L. Richie, D. J. Fryauff, H. Picarima, C. Ohrt, D. Tang, D. Braitman, G. S. Murphy, H. Widjaja, E. Tjitra, A. Ganjar, T. R. Jones, H. Basri, and J. Berman. 1999. Malaria prophylaxis using azithromycin: a double-blind placebo-controlled trial in Irian Jaya, Indonesia. Clin. Infect. Dis 28:74-81.
22. Treadway, G., and D. Pontani. 1996. Paediatric safety of azithromycin: worldwide experience. J. Antimicrob. Chemother. 37(Suppl. C):143-149.
23. Tseng, A. L., L. Dolovich, and I. E. Salit. 1997. Azithromycin-related ototoxicity in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24:76-77.
24. Wallace, M. R., L. K. Miller, M. T. Nguyen, and A. R. Shields. 1994. Ototoxicity with azithromycin. Lancet 343:241.
25. Zuckerman, J. M., and K. M. Kaye. 1995. The newer macrolides. Infect. Dis. Clin. N. Am. 9:731-745.